The multidisciplinary rectal cancer treatment: Main convergences, controversial aspects and investigational areas which support the need for an European Consensus

Radiotherapy and Oncology

Volumn 76, Issue 3, 2005, Pages 241-250

  Valentini, Vincenzo ^a,n   Glimelius, Bengt ^b   Minsky, Bruce D ^c   Van Cutsem, Eric ^d   Bartelink, Hanry ^e   Beets Tan, Regina G H ^f   Gerard, Jean Pierre ^g   Kosmidis, Paris ^h   Pahlman, Lars ^b   Picciocchi, Aurelio ^a   Quirke, Phil ⁱ   Tepper, Joel ^j   Tonato, Maurizio ^k   Van De Velde, Cornelius J ^l   Cellini, Numa ^a   Latini, Paolo ^m  

^a CATHOLIC UNIVERSITY   (Italy)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CENTRE ANTOINE LACASSAGNE   (France)

^h HYGEIA HOSPITAL   (Greece)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

^j UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^k Università degli Studi   (Italy)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m UNIVERSITY OF PERUGIA   (Italy)

ⁿ Istituto di Radiologia di Universita Cattolica del Sacro Cuore di Roma   (Italy)

more..

Author keywords

Chemotherapy; Combined modality treatment; Postoperative radiotherapy; Preoperative radiotherapy; Rectal cancer; Staging; Treatment outcome

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

BARIUM ENEMA; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; DIGITAL RECTAL EXAMINATION; ENDOSCOPY; HUMAN; ITALY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUESTIONNAIRE; RECTUM; RECTUM CANCER; SPHINCTER; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ENDOSCOPY, GASTROINTESTINAL; HEALTH CARE SURVEYS; HUMANS; INTERNATIONAL COOPERATION; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS;

EID: 25844442570     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2005.07.001     Document Type: Conference Paper

References (64)

1. NIH consensus conference Adjuvant therapy for patients with colon and rectal cancer JAMA 264 11 1990 1444 1450
2. B. Barbaro, A. Schulsinger, and V. Valentini The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy Int J Radiat Oncol Biol Phys 43 1999 1043 1047
3. M. Gavioli, A. Bagni, and I. Piccagli Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer Dis Colon Rectum 43 2000 1075 1083
4. R.G.H. Beets-Tan, and G.L. Beets Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorec Dis 18 2003 385 391
5. R.G.H. Beets-Tan, G.L. Beets, and R.F.A. Vliegen Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery Lancet 357 2001 497 504
6. G. Brown, C.J. Richards, and M.W. Bourne Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison Radiology 227 2003 371 377
7. A. Dzik-Jurask, C. Domenig, and M. George Diffusion MRI for prediction of response of rectal cancer to chemoradiation Lancet 360 2002 307 308
8. J.G. Guillem, H.G. Moore, and T. Akhurst Prospective evaluation of the prognostic significance of FDG-PET assessment of rectal cancer response to preoperative chemoradiation Proc ASCO 21 2002 145a
9. B.D. Minsky, A.M. Cohen, and W.E. Enker Combined modality therapy of rectal cancer: Decreased acute toxicity with the pre-operative approach J Clin Oncol 10 1992 1218 1224
10. C. Camma, M. Giunta, F. Fiorica, L. Pagliaro, A. Craxi, and M. Cottone Preoperative radiotherapy for resectable rectal cancer: A meta-analysis JAMA 284 2000 1008 1015
11. Colorectal Cancer Collaborative Group Adjuvant therapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials Lancet 358 2001 1291 1304
12. A.J. Munro, and A. Bentley Adjuvant radiotherapy in operable rectal cancer: a systematic review 13 ed 2002 pp. 31-42
13. B. Glimelius, H. Grönberg, J. Järhult, and A. Wallgren Cavallin-ståhl E A systematic overview of radiation therapy effects in rectal cancer Acta Oncol 42 2003 476 492
14. Swedish Rectal Cancer Trial Improved survival with preoperative radiotherapy in resectable rectal cancer N Engl J Med 336 1997 980 987
15. E. Kapiteijn, C.A.M. Marijnen, and I.D. Nagtegaal Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer New Engl J Med 345 2001 638 646
16. C.J.H. van de Velde Preoperative radiotherapy and TME-surgery for rectal cancer: detailed analysis in relation to quality control in a randomized trial Proc ASCO 21 2002 127a
17. C.A.M. Marijnen, E. Kapiteijn, and C.J.H. van de Velde Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial J Clin Oncol 20 2002 817 825
18. G. Valero, J.A. Lujan, and Q. Hernandez Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications Int J Colorec Dis 18 2003 495 499
19. M.W. Onaitis, R.B. Noone, and R. Fields Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival Ann Surg Oncol 8 2001 801 806
20. N.A. Janjan, C. Crane, and B.W. Feig Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer Am J Clin Oncol 24 2001 107 112
21. S.P. Hiotis, S.M. Weber, and A.M. Cohen Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients J Am Coll Surg 194 2002 131 136
22. L. Ruo, S. Tickoo, and D.S. Klimstra Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy Ann Surg 236 2002 75 81
23. V. Valentini, C. Coco, and A. Picciocchi Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long term analysis of 165 patients Int J Radiat Oncol Biol Phys 53 2002 664 674
24. J. Garcia-Aguilar, E. Hernandez de Anda, and P. Sirivongs A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision Dis Colon Rectum 46 2003 298 304
25. M. Mohiuddin, M. Hayne, and W.F. Regine Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/recurrent rectal cancers Int J Radiat Oncol Biol Phys 48 2000 1075 1080
26. B. Cedermark, H. Johansson, L.E. Rutqvist, and N. Wilking The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma Cancer 75 1995 2269 2275
27. J.F. Bosset, G. Calais, and L. Mineur Preoperative radiotherapy (Preop RT) in rectal canacer: effect and timing of additional chemotherapy (CT) 5 year results of the EORTC 22921 trial Proc ASCO 2005 3505
28. J. Gerard, F. Bonnetain, and O. Conroy Preoperative (preop) radiotherapy (RT) +5FU/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial Proc. ASCO 2005 3504
29. K. Bujko, M.P. Nowacki, and A. Nasierowska-Guttmejer Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy Radiother Oncol 72 2004 15 24
30. R. Sauer, H. Becker, W. Hohenberger, and C. Rodel Preoperative versus postoperative chemoradiotherapy for rectal cancer N Engl J Med 351 2004 1731 1740
31. W. Graf, M. Dahlberg, and M.M. Osman Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients Radiother Oncol 43 1997 133 137
32. C.A.M. Marijnen, I.D. Nagtegaal, and E.K. Kranenbarg No downstaging after short-term preoperative radiotherapy in rectal cancer patients J Clin Oncol 19 2001 1976 1984
33. P. Rouanet, B. Saint Aubert, and C. Lemanski Restorative and nonrestorative surgery for low rectal cancer after high dose radiation. Long term oncologic and functional results Dis Colon Rectum 45 2002 305 315
34. R. Wagman, B.D. Minsky, and A.M. Cohen Sphincter preservation with preoperative radiation therapy and coloanal anastomosis: long term follow-up Int J Radiat Oncol Biol Phys 42 1998 51 57
35. V. Valentini, C. Coco, and N. Cellini Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies Int J Radiat Oncol Biol Phys. 51 2001 371 383
36. C. Rodel, G.G. Grabenbauer, and T. Papadopoulos Phase I/II trial of capecitibine, oxaliplatin, and radiation for rectal cancer J Clin Oncol 21 2003 3098 3104
37. J.P. Gerard, O. Chapet, and C. Nemoz Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial J Clin Oncol 21 2003 1119 1124
38. C. Aschele, M.L. Friso, and S. Pucciarelli A phase I-II study of weekly oxaliplatin (OXA) 5-fluorouracil (FU) continuous infusion (CI) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC) Proc ASCO 21 2002 132a
39. V. Voelter, R. Stupp, and M. Matter Preoperative hyperfractionated accelerated radiotherapy (HART) and concomitant CPT-11 in locally advanced rectal carcinoma: a phase I study Int J Radiat Oncol Biol Phys 56 2003 1288 1294
40. E.L. Levine, S. Gollins, and S. Susnerwala Phase I/II study of irinotecan (CPT-11), 5-fluorouracil and concurrent radiotherapy for the treatment of T3-T4 locally advanced inoperable rectal cancer Proc ASCO 22 2003 345
41. J. Souglakos, N. Androulakis, and D. Mavroudis Multicenter dose-finding study of concurrent capecitabine and radiotherapy as adjuvant treatment for operable rectal cancer Int J Radiat Oncol Biol Phys 56 2003 1284 1287
42. J. Dunst, T. Reese, and T. Sutter Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer J Clin Oncol 20 2002 3983 3991
43. Y. Francois, C.J. Nemoz, and J. Baulieux Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial J Clin Oncol 17 1999 2396 2402
44. J.P. Gerard, O. Chapet, and C. Nemoz Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon r96-02 randomized trial J Clin Oncol 22 2004 2404 2409
45. J.E. Krook, C.G. Moertel, and L.L. Gunderson Effective surgical adjuvant therapy for high-risk rectal carcinoma N Engl J Med 324 1991 709 715
46. M.J. O'Connell, J.A. Martenson, and H.S. Wieand Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery N Engl J Med 331 1994 502 507
47. J.E. Tepper, M.J. O'Connell, and D. Niedzwiecki Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control - final report of Intergroup 0114 J Clin Oncol 20 2002 1744 1750
48. S.R. Smalley, J. Benedetti, and S. Williamson Intergroup 0144 - phase III trial of 5-FU based chemotherapy regimens plus radiotherapy (XRT) in postoperative adjuvant rectal cancer. Bolus 5-FU vs. prolonged venous infusion (PVI) before and after XRT + PVI vs. bolus 5-FU + leucovorin (LV) + Levamisole (LEV) before and after XRT + bolus 5-FU + LV Proc ASCO 22 2003 251
49. J.H.L. Lee, J.H. Lee, and J.H. Ahn Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: A preliminary report J Clin Oncol 20 2002 1751 1758
50. C.G. Willett, K. Badizadegan, and M. Ancukiewicz Prognostic factors in stage T3N0 rectal cancer. Do all patients require post-operative pelvic irradiation and chemotherapy? Dis Colon Rectum 42 1999 167 173
51. N.B. Merchant, J.G. Guillem, and P.B. Paty T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy J Gastrointest Surg 3 1999 642 647
52. F.L. Green, A.K. Stewart, and H.J. Norton A new TNM staging strategy for node-positive (stage III) rectal cancer: an analysis of 5998 patients Proc ASCO 22 2003 251
53. C.F. Kollmorgen, A.P. Meagher, and J.H. Pemberton The long term effect of adjuvant postoperative chemoradiotherapy for rectal cancer on bowel function Ann Surg 220 1994 676 682
54. L.L. Gunderson, D.J. Sargent, and J.E. Tepper Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis J Clin Oncol 22 2004 1785 1796
55. M.A. Rothenberg, A.M. Oza, and R.H. Bigelow Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial J Clin Oncol 21 2003 2059 2069
56. R.M. Goldberg, R.F. Morton, and D.J. Sargent N9741: oxaliplatin (Oxal) or CPT-11+5-fluorouracil (5-FU)/Leucovorin (LV) or oxal + CPT-11 in advanced colorectal cancer (CRC). Updated efficacy and quality of life Proc ASCO 22 2003 252
57. L.B. Saltz, J.V. Cox, and C. Blanke Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer N Engl J Med 343 2000 905 914
58. D. Cunningham, Y. Humblet, and S. Siena Cetuximab (C225) alone or in combination with irinotecan (CPT-11) in patients with epidermal growth factor receptor (EGFR)-positive, irinotecan-refractory metastatic colorectal cancer (MCRC) Proc ASCO 22 2003 252
59. A. Martoni, E. Mini, and C. Pinto Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II study Anticancer Res 23 2003 687 691
60. B. Neri, L. Doni, and C. Fulignati Raltitrexed plus oxaliplatin as a first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial Anticancer Drugs 13 2002 719 724
61. J.F. Seitz, J. Bennouna, and B. Paillot Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients Ann Oncol 13 2002 1072 1079
62. E. Van Cutsem, P.M. Hoff, and P. Harper Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomized, phase III trials Br J Cancer 90 2004 1190 1197
63. S. Cascinu, F. Graziano, and F. Ferrau Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD) Ann Oncol 13 2002 716 720
64. P. Nygren, H. Sorbye, P. Österlund, and P. Pfeiffer Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: An Acta Oncologica expert report Acta Oncol 44 2005 203 217